Prognostic value of C-reactive protein in chronic obstructive pulmonary disease.
To establish whether C-reactive protein (CRP) is an independent predictor of all-cause mortality and hospitalization in chronic obstructive pulmonary disease (COPD), we followed 200 patients with COPD and 201 age- and gender -matched controls for a median time of 4.2 years (range, 0.2-5.1 years). Airflow obstruction was rated moderate if forced expiratory volume in one second (FEV(1)) was 50-69% of the predicted value, or severe if FEV(1) was <50%. The CRP level was categorized as low (≤3 mg/L) or high (>3 mg/L). The hazard of death was estimated by a proportional hazard regression model, using controls with low CRP as the reference category. Fifty subjects died: 41 (21%) among the COPD and 9 (4%) among the controls (p < 0.0001). The hazard of death in moderate COPD was not significantly higher than in the reference category, independently of the CRP level. In severe COPD with a low CRP, the hazard of death is 3.4 times higher than in the reference category (p = 0.008); in severe COPD and a high CRP it is 9.6 times higher (p < 0.0001). The rate of hospitalization in COPD patients with a high CRP is 1.9 times higher than in those with a low CRP [95% confidence interval (CI), 1.2-3.2]. In severe COPD, it is 6.9 times higher than in moderate COPD (95% CI, 3.8-12.7). A high CRP level is a significant amplifier of the risk of death only in severe COPD. The degree of airflow obstruction is a strong independent predictor of COPD-related outcomes.
Dipartimento di Area Critica Medico-Chirurgica, Università di Firenze, Viale Morgagni 85, 50134 Florence, Italy. massimo.miniati@unifi.it
Massimo
M
Miniati
Simonetta
S
Monti
Matteo
M
Bottai
Franca
F
Cocci
Edo
E
Fornai
Valter
V
Lubrano
D000368:Aged; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000032:analysis*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D029424:Pulmonary Disease, Chronic Obstructive / Q000097:blood* / Q000401:mortality
D015415:Biomarkers; D002097:C-Reactive Protein
Thorax. 2006 Oct;61(10):849-53
16738034
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1207-14
18310480
Eur Respir J. 2008 Oct;32(4):931-7
18614560
Eur Respir J. 2008 Mar;31(3):509-15
18057056
N Engl J Med. 2007 Feb 22;356(8):775-89
17314337
Am J Respir Crit Care Med. 2006 Jan 1;173(1):79-83
16368793
Eur Respir J. 2005 Aug;26(2):319-38
16055882
Am J Respir Crit Care Med. 2002 Aug 15;166(4):485-9
12186825
Am Rev Respir Dis. 1981 Jun;123(6):659-64
7271065
Thorax. 2006 Jan;61(1):23-8
16143583
Am J Respir Crit Care Med. 2004 Oct 1;170(7):760-5
15229100
Thorax. 2006 Jan;61(1):17-22
16055618
Chest. 2008 Jun;133(6):1336-1343
18339787
Circulation. 2003 Mar 25;107(11):1514-9
12654609
BMC Med Genet. 2010 Jan 15;11:7
20078883
Am Rev Respir Dis. 1965 Jan;91:69-76
14260002
Eur Respir J. 2005 Oct;26(4):720-35
16204605
MMWR Surveill Summ. 2002 Aug 2;51(6):1-16
12198919
Hum Mutat. 2006 Jan;27(1):103-9
16278826
N Engl J Med. 2004 Mar 4;350(10):1005-12
14999112
Am Rev Respir Dis. 1992 Jun;145(6):1321-7
1595997
Am J Respir Crit Care Med. 2007 Feb 1;175(3):250-5
17053205